UZ Leuven treats first patient in Europe on Varian Halcyon

By News Release
0  Votes

Varian has announced that an 80-year-old male with head and neck cancer became the first patient in Europe to be treated on the Halcyon system at University Hospitals Leuven (UZ Leuven) in Belgium. Halcyon is an advanced cancer treatment system that is more comfortable for the patient while delivering ease-of-use for healthcare providers, accelerated installation time frames, expedited commissioning, simplified training, and automated treatment.

Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is designed to expand the availability of high-quality cancer care globally and help save the lives of millions more cancer patients. It is well-suited to handle the majority of cancer patients, offering advanced treatments for lung, esophagus, brain, head and neck, and many other forms of cancer.

"We selected the Halcyon system because of its potential to accelerate the treatment workflow and allow for a much closer connection between the patient and therapist," said professor Karin Haustermans, MD, chair of the department, UZ Leuven. "Having now completed our first treatments I can say that Halcyon lived up to its promise of a more efficient workflow and better integration of imaging and treatment, which resulted in a much faster overall treatment time."

"We are very proud to have partnered with UZ Leuven on making Halcyon treatments available to patients in Europe just two months after the hospital ordered this new system," said Kolleen Kennedy, president of Varian's Oncology Systems business. "The treatments beginning at UZ Leuven are another important step in continuing our efforts of advancing cost-effective cancer care worldwide."

Back To Top

UZ Leuven treats first patient in Europe on Varian Halcyon .  Appl Rad Oncol. 

By News Release| October 17, 2017

About the Author

News Release

News Release

 



Copyright © Anderson Publishing, Ltd

 2017